成年人缺铁问题:综述
Michael Auerbach1,2, Thomas G DeLoughery3, Jennifer S Tirnauer4
1Auerbach Hematology and Oncology, Baltimore, Maryland.
JAMA
|March 30, 2025
概括
铁缺乏影响全球20亿人, 诊断涉及费里和转蛋白和,口服铁作为第一线治疗,以及特定情况下的静脉铁.
科学领域:
- 内部医学
- 血液学
背景情况:
- 缺铁, 带有或没有贫血, 影响全球20亿和美国成年人14%.
- 全球有12亿人患有缺铁性贫血,
研究的目的:
- 总结铁缺乏症和缺铁性贫血的流行情况,症状,原因,诊断和治疗.
- 强调及时诊断和适当管理的重要性.
主要方法:
- 关于缺铁和缺铁性贫血的现有文献的审查.
- 对流行数据,常见症状和风险因素的分析.
- 诊断标准和治疗方法的总结
主要成果:
- 缺铁会发展为缺铁性贫血,
- 常见的原因包括出血,吸收受损,摄入不足和怀孕.
- 诊断依赖于低血清费里或转激素和.
结论:
- 铁缺乏和贫血普遍存在,影响全球健康.
- 通过费里和转蛋白和测试进行早期诊断至关重要.
- 口服铁是主要的治疗方法,静脉注射铁只适用于特定的患者群体.
相关概念视频
The Periodic Table and Organismal Elements
161.6K
OverviewElements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally-occurring, and fewer still are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.The Periodic Table Provides Information...
161.6K
Hemoglobin
8.8K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
8.8K
Disorders of Erythrocytes
2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Factors Affecting Erythropoiesis
8.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
8.3K
Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K


